296
Participants
Start Date
November 27, 2017
Primary Completion Date
May 23, 2024
Study Completion Date
May 23, 2024
ZX008 0.2 or 0.8 mg/kg/day
ZX008 drug product is an oral aqueous solution of fenfluramine hydrochloride. The product is sugar free and is intended to be compatible with a Ketogenic Diet.
Matching Placebo
Placebo will be administered twice a day (BID) in equally divided doses.
Ep0214 142, New York
Ep0214 150, Hartsdale
Ep0214 139, York
Ep0214 149, Washington D.C.
Ep0214 140, Bethesda
Ep0214 117, Atlanta
Ep0214 115, Gulf Breeze
Ep0214 141, Orlando
Ep0214 121, Orlando
Ep0214 104, Miami
Ep0214 131, Cleveland
Ep0214 147, Royal Oak
Ep0214 136, Grand Rapids
Ep0214 132, Saint Paul
Ep0214 109, Rochester
Ep0214 110, Chicago
Ep0214 146, Dallas
Ep0214 126, Fort Worth
Ep0214 103, Aurora
Ep0214 106, Salt Lake City
Ep0214 107, Tucson
Ep0214 101, San Francisco
Ep0214 143, Portland
Ep0214 125, Tacoma
Ep0214 144, Los Angeles
Ep0214 112, Boston
Ep0214 105, Hackensack
Ep0214 118, Livingston
Ep0214 120, Philadelphia
Ep0214 145, San Antonio
Ep0214 301, Heidelberg
Ep0214 302, South Brisbane
Ep0214 802, Brussels
Ep0214 803, Brussels
Ep0214 801, Edegem
Ep0214 204, Toronto
Ep0214 201, Vancouver
Ep0214 701, Dianalund
Ep0214 1004, Bordeaux
Ep0214 1006, Bron
Ep0214 1005, Lille
Ep0214 1007, Marseille
Ep0214 1001, Paris
Ep0214 1002, Paris
Ep0214 902, Bielefeld
Ep0214 906, Freiburg im Breisgau
Ep0214 905, Jena
Ep0214 908, Kiel
Ep0214 903, Radeberg
Ep0214 901, Vogtareuth
Ep0214 1211, Bologna
Ep0214 1201, Florence
Ep0214 1204, Genova
Ep0214 1206, Roma
Ep0214 1208, Roma
Ep0214 1510, Fukuoka
Ep0214 1505, Niigata
Ep0214 1501, Okayama
Ep0214 1507, Osaka
Ep0214 1504, Ōmura
Ep0214 1508, Sapporo
Ep0214 1506, Shinjuku-ku
Ep0214 1502, Shizuoka
Ep0214 1604, Guadalajara
Ep0214 1401, Zwolle
Ep0214 1702, Bydgoszcz
Ep0214 1701, Krakow
Ep0214 1105, Barcelona
Ep0214 1107, Barcelona
Ep0214 1101, Mirasierra
Ep0214 1102, Pamplona
Ep0214 502, Gothenburg
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
INDUSTRY